Immunologix Laboratories

The decision makers in Immunologix Laboratories are Chris Stebbins, Devangi Mehta, Jason Ambrosius, etc. Click to Find Immunologix Laboratories decision makers emails.

Immunologix Laboratories specializes in ligand binding-based bioanalysis, providing a range of services including immunoassay method development and validation, immunogenicity assays, pharmacokinetic (PK) immunoassays, and biomarker assay sciences. Our laboratory capabilities are compliant with Good Laboratory Practice (GLP) and Good Clinical Practice (GCP) standards, ensuring high-quality and reliable results for our clients.

Immunologix Laboratories serves as a scientific partner for pharmaceutical and biotech companies by offering expert consultation and comprehensive bioanalytical services. Our Translational Sciences team collaborates closely with clients to design and implement studies that meet regulatory requirements, facilitating the development of therapeutics from preclinical stages through clinical trials. We aim to streamline the drug development process and enhance the success rate of new therapies.

The process for developing and validating an immunoassay at Immunologix Laboratories begins with a thorough assessment of the client's requirements and the specific analyte of interest. Our team then designs the assay, optimizing conditions to ensure sensitivity, specificity, and reproducibility. Once the assay is developed, it undergoes rigorous validation according to GLP and GCP standards, including assessments of accuracy, precision, linearity, and stability. We provide comprehensive documentation throughout the process to support regulatory submissions.

Yes, Immunologix Laboratories offers services in biomarker assay sciences, which include biomarker discovery, development, and validation. Our team employs advanced techniques and methodologies to identify potential biomarkers that can be used for patient stratification, disease monitoring, and therapeutic efficacy assessment. We work closely with clients to ensure that the biomarker assays are robust, reproducible, and suitable for their specific research or clinical needs.

Immunogenicity assays are critical tests that evaluate the immune response to therapeutic proteins, including monoclonal antibodies and vaccines. These assays help determine whether a therapeutic agent elicits an unwanted immune response that could affect its safety and efficacy. At Immunologix Laboratories, we conduct comprehensive immunogenicity assessments to support our clients in understanding the immunological profile of their products, ensuring compliance with regulatory expectations and enhancing the overall development strategy.

To get in touch with Immunologix Laboratories for a consultation, you can visit our website at http://www.immunologixlabs.com and fill out the contact form provided. Alternatively, you can reach us directly via email or phone, both of which are listed on our contact page. Our team is ready to discuss your specific needs and how we can support your research and development efforts.